; Anti-Neoplastic Agents Market Size, Industry Share, Forecast, 2030

Anti-Neoplastic Agents Market

Anti-Neoplastic Agents Market By Product Type (Chemotherapeutic agents, Biological/immunotherapeutic agent, Personalized medicine and Others); By Cancer Type (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/lung Cancer and Other); By End User (Hospitals, Clinics, Research Institutes, Cancer Rehabilitation Centers and Others); and Region - Global Analysis of Market Size, Share & Trends for 2019- 2020 and Forecasts to 2030

Published on: Mar-2021
Report Code: FG HC 00588
No. of Pages: 174
Report Format: PDF

Product Overview

Anti-neoplastic agents are the drugs that prevent the development of neoplasm, a kind of tumor. Antineoplastic agents are also known as anticancer, chemotherapy, chemo, cytotoxic drugs. These agents are available in many forms-some are in the form of pills and others are taken as injections. These agents travel into the human body and destroy the cancerous cells and thus aids in the management of cancer. Many anti-neoplastic agents are available commercially for the therapy of various kinds of cancers including Gleevec, Oncotrex, Cytarabine, Leukeran, Near. These drugs or agents are not only used for different cancers but are used in combination with surgery, radiotherapy, immunotherapy, targeted therapy hormone therapy for many solid tumors, especially metastatic.

Market Highlights

Global Anti-Neoplastic Agents market is expected to project a notable CAGR in 2030.

Global Anti-Neoplastic Agents Market to surpass USD XXXX million by 2030 from USD XXXX million in 2019 at a CAGR of XX.X%, in the coming years i.e., 2020-30. The global Anti-Neoplastic Agents market is expected to observe growth in the future owing to increasing cases of cancers and the geriatric population. Change in lifestyle of people and the need for a cost-effective cancer cure are the key factors attributing to the growth of the antineoplastic agent’s market. Additionally, rapid innovations, increasing funding from the government, and favorable reimbursement policies are estimated to fuel the global anti-neoplastic agent market.

Global Anti-Neoplastic Agents Market: Segments

Chemotherapeutic agents’ segment to grow with the highest CAGR during 2020-30

Global Anti-Neoplastic Agents Market is segmented by Type into Chemotherapeutic agents, Biological/immunotherapeutic agent, Personalized medicine, and Others. The chemotherapeutic agents' segment held the largest market share of XX.X% in the year 2019 and is expected to dominate the global market in the coming years. Chemotherapeutic agents are used to preventing the uncontrolled growth and proliferation of cancer cells. Easy accessibility of these drugs is expected to grow the anti-neoplastic market.

Hospital segment to grow with the highest CAGR during 2020-30

Global Anti-Neoplastic Agents Market is segmented by the end user into hospitals, clinics, research institutes, cancer rehabilitation centers, and Others. The hospital segment held the largest market share of XX.X% in the year 2019 and is expected to maintain this trend throughout the forecast period. With the increasing cases of cancer, a vast number of cancer patients are being hospitalized in hospitals every year.

Market Dynamics

Drivers

Growing Cases of Cancer

Growing incidences of cancer and an increasing geriatric population is estimated to grow the anti-neoplastic agent market. With the change in lifestyle of consumers, the risk associated with cancer is increasing. This has attracted the attention of various pharmaceutical companies to get into the anti-neoplastic agent market leading to the growth of the anti-neoplastic agents’ market globally.

Technological Advancements

Several technological advances in the field of personalized medicine offers a huge opportunity to manufacturers of anti-neoplastic agents. Additionally, due to the mounting prevalence of cancer, the multinational firms are increasing investment in cancer research which is projected to boost the global market for anti neo plastic agents.

Restraints

High Development Cost

Development of anti-neoplastic agents involves high costs due to which they are expensive. The high cost of these agents is not affordable by some consumers which are anticipated to limit the growth of global anti neoplastic agents market.

Global Anti-Neoplastic Agents Market: Key Players
  • Hoffmann-La Roche
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Baxter Healthcare Corporation
  • Boehringer Ingelheim GmbH
  • Aspen Global Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Pvt. Ltd.
  • Merc & Co.
  • Pfize Inc.,
  • Accord Healthcare, Inc.
  • Genentech, Inc.
  • Lundbeck LLC
  • AbbVie Inc.
  • Other Prominent Players

Global Anti-Neoplastic Agents Market: Regions

Global Anti-Neoplastic Agents market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA. Global Anti-Neoplastic Agents market in North America held the largest market share of XX.X% in the year 2019 owing to high prevalence of malignant neoplasm. Besides, excellent healthcare infrastructure and a number of non-government institutes offering cancer management services in this region are expected to proliferate the global anti-neoplastic market. A disorganized lifestyle coupled with an unhealthy diet is likely to increase the demand for anti-neoplastic agents in the near future.

Global Anti-Neoplastic Agents market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global Anti-Neoplastic Agents market report also contains analysis on:

Anti-Neoplastic Agents Market Segments:

  • By Product Type
    • Chemotherapeutic agents
    • Biological/immunotherapeutic agent
    • Personalized medicine 
    • Others
  • By Cancer Type
    • Blood cancer
    • Breast cancer
    • Gastrointestinal cancer
    • Prostate cancer
    • Respiratory/lung cancer
    • Other
  • By End-user
    • Hospitals
    • Clinics
    • Research institutes
    • Cancer rehabilitation centers
    • Others
  • Anti-Neoplastic Agents Market Dynamics
  • Anti-Neoplastic Agents Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients